• The total number of diagnosed lifetime prevalent cases of schizophrenia in the countries under study will increase by 6% over the forecast period, from 9.4 million in 2016 to 10 million in 2026.
  • The number of diagnosed lifetime prevalent cases of schizophrenia will evolve over time as a function of demographic trends. The dominant factor determining the change in prevalent cases of schizophrenia over the next ten years will be changes in the absolute size of the population at risk.

Table of contents

  • Schizophrenia - Epidemiology - Emerging Markets
    • Introduction
      • Key Findings
      • Epidemiology Data
      • Methods
        • Diagnosed Prevalent Cases
        • Diagnosed Incident Cases
        • Percentage Drug-Treated
        • Lifetime DALYs Gained
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Schizophrenia
          • Studies Excluded from the Analysis of Schizophrenia
        • Risk/Protective Factors
          • Risk/Protective Factors for Schizophrenia
        • Bibliography

      Author(s): Mudasir Khan, M.P.H.

      Mudasir works as an associate epidemiologist within the epidemiology team at Decision Resources Group. He specializes in developing epidemiological forecasts for multiple indications within the DRG syndicated portfolio.

      Mudasir holds a masters in public health specializing in epidemiology from TISS, Mumbai.


      Related Reports

      Schizophrenia - Landscape & Forecast - Disease Landscape And Forecast G7

      The schizophrenia therapy market is very crowded. Many of the antipsychotic therapies are generic, although newer oral atypical antipsychotics (e.g., Intra-Cellular Therapies’ Caplyta) are al...

      View Details

      Schizophrenia| Disease Landscape and Forecast | G7 | 2020

      The schizophrenia therapy market is very crowded. Many of the antipsychotic therapies are generic, although newer oral atypical antipsychotics (e.g., Intra-Cellular Therapies’ Caplyta) are also ava...

      View Details

      Schizophrenia - Special Topics - Special Topics Evolving Market Dynamics In Schizophrenia US

      The schizophrenia therapy market is dominated by oral and long-acting injectable (LAI) antipsychotics, which are primaril...

      View Details

      Schizophrenia - Special Topics - Special Topics: Agitation In Bipolar And Schizophrenia (US)

      Agitation is a common behavioral aspect often associated with bipolar disorder (BPD) and schizophrenia. It often manifests in the form of tension, violence, or...

      View Details